Colgate Q2 Results: Sales Grow, North America Weak

Colgate Q2 results show sales growth and margin expansion; company raised base EPS outlook but warned weak North America demand may dent positioning.

July 31, 2026·2 min read
View all news articles
Flat filled vector of a toothpaste tube with a cracked shell symbolizing Colgate Q2 results and North America weakness.

KEY TAKEAWAYS

  • Net sales rose 4.9% to $5,361 million and gross margin expanded 140 bps to 61.5%.
  • Base Business EPS rose 8% to $0.99 and company raised base EPS growth outlook to mid single digits.
  • North America organic sales fell 3.0% on weaker volumes and retailer destocking while Latin America led growth.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Colgate-Palmolive reported Colgate Q2 results on July 31, 2026, showing companywide sales growth and margin expansion while management said muted North American demand and potential tariff headwinds cloud near-term prospects for investors.

Sales and Margin Gains

For the quarter ended June 30, 2026, Colgate-Palmolive said in a press release that net sales rose 4.9% year over year to $5.36 billion. Organic sales increased 2.4%, including a 0.4% negative impact from lower private-label pet food sales. Reported volume rose 0.9%, with organic volume up 0.8%.

Base Business earnings per share (EPS), a measure adjusted for one-time items, rose 8% to $0.99, driven by Base Business earnings of $797 million. On a generally accepted accounting principles (GAAP) basis, EPS was $0.86, down 5%, and net income fell to $693 million from $743 million a year earlier.

Gross profit margin expanded 140 basis points to 61.5%, reflecting improved reported and adjusted profitability. Through the first six months of 2026, the company generated $1.74 billion in net cash from operations. Free cash flow margin for the quarter was 16.2%, roughly flat with the prior year.

Regional Performance and Guidance

North America, where the Oral, Personal & Home Care division accounts for about 17% of company sales, was the weakest region. Sales fell 3.0% year over year, with organic sales and volume declining 3.0% and 3.9%, respectively. Management attributed the weakness to slower category growth, increased competition, market-share losses, and inventory reductions at key retailers.

Latin America posted the strongest gains, with net sales up 13.7%, organic sales up 5.3%, and volume up 2.6%. Europe, the Middle East, and Africa grew as well, with net sales rising 3.5%, organic sales 2.0%, and volume 3.2%. Management also cited solid contributions from Asia Pacific and emerging markets including India, Brazil, Mexico, and China. Hill’s Pet Nutrition sales increased 3.4% year over year.

The company reaffirmed its full-year 2026 outlook, expecting net sales growth of 2% to 6%, including a low-single-digit positive impact from foreign exchange. Organic sales are projected to rise 1% to 4%. Colgate raised the base of its adjusted earnings outlook to mid-single-digit Base Business EPS growth for the year.

Reported revenue was broadly in line with consensus estimates, while adjusted EPS beat by about $0.04, or roughly 4% to 4.5%. Investors weighed the stronger-than-expected adjusted profit against ongoing North American softness and tariff risks.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Microsoft Earnings: Record Cloud Growth Strengthens Case

Microsoft Earnings: Record Cloud Growth Strengthens Case

Microsoft earnings on July 29, 2026 showed accelerating Azure and cloud revenue that lifted operating income and bolstered the cloud-led FY27 trading case.

Big Tech AI Spending Sparks Cash-Flow Reckoning

Big Tech AI Spending Sparks Cash-Flow Reckoning

Big Tech AI spending rose as Alphabet raised 2026 capex to $195-$205 billion and posted negative free cash flow, pressuring sector positioning.

Palantir Earnings: Options Point to Big Move

Palantir Earnings: Options Point to Big Move

Palantir earnings on Aug. 3 focus on rapid revenue and guidance, while options pricing implies an ~9% move that will amplify stock and options volatility.

AutoNation Second Quarter Earnings: Revenue Falls, EPS Rises

AutoNation Second Quarter Earnings: Revenue Falls, EPS Rises

AutoNation Second Quarter Earnings showed revenue down modestly while adjusted EPS rose, shifting trader focus to after-sales growth and buybacks.

First Solar Q2 2026 Earnings Show Margin Strength

First Solar Q2 2026 Earnings Show Margin Strength

First Solar Q2 2026 earnings delivered strong margins and an EPS beat while late-July class-action notices add a legal overhang for traders.

Moderna Q2 2026 Earnings Mixed as Vaccine Sales Weigh

Moderna Q2 2026 Earnings Mixed as Vaccine Sales Weigh

Moderna Q2 2026 earnings were mixed as revenue split analysts; management tightened expenses and raised year-end cash outlook ahead of Aug. 5 flu decision.